Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
Condition(s):Colorectal CancerLast Updated:April 15, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Colorectal CancerLast Updated:April 15, 2016Completed
Condition(s):EpilepsyLast Updated:September 28, 2022Completed
Condition(s):Infection, Human Immunodeficiency VirusLast Updated:September 19, 2018Terminated
Condition(s):Refractory Chronic CoughLast Updated:February 15, 2024Recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:June 28, 2023Active, not recruiting
Condition(s):Chemotherapy-induced Nausea and Vomiting (CINV)Last Updated:June 3, 2021Unknown status
Condition(s):Bladder Urothelial Carcinoma; Stage IV Bladder Cancer AJCC v8; Stage IVA Bladder Cancer AJCC v8; Stage IVB Bladder Cancer AJCC v8Last Updated:March 7, 2024Active, not recruiting
Condition(s):Ulcerative ColitisLast Updated:April 10, 2019Terminated
Condition(s):HIV-1Last Updated:August 17, 2015Completed
Condition(s):Laryngeal NeoplasmsLast Updated:March 9, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.